Ben Toth
Research Subjects
Ben Toth has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Ian Harvey
Department of Social Medicine, University of Bristol, UK
2 shared publicationsJ. A. Muir Gray
Director, Clinical Process, Knowledge and Safety, National Programme for IT
2 shared publications- Alison Turner
National electronic Library for Health, NHS Information Authority, Birmingham, UK
1 shared publication Anne Brice
Editor, National electronic Library for Health
1 shared publicationC Gordon
Royal Brompton & Harefield NHS Trust, UK
1 shared publicationDavid Mant
Department of Primary Health Care, University of Oxford
1 shared publication
Latest Publications
- Open Access
- 3 October 2025
- Published by Center for Open Science in SocArXiv
Towards a historical ontology of racial knowledge - the epistemic space of race
This paper outlines an epistemic space in which race is neither a biological fact nor a social construct. At stake is a tractable analysis of race across public discourse, science, and law which doesn’t reduce to the essentialism of biology or society.Drawing on Michel Foucault’s archaeology, biopolitics, and dispositif, and reading them alongside Kant’s Anthropology, I argue that race persists not because it is true or false, but because it is realised “within the true” - that is, within epistemic norms and institutional apparatuses that produce what Steven Pinker calls common knowledge, Michael Hardimon calls enlightened commonsense. Racial thinking is exemplified in Aaron Panofsky’s observation that “one can believe that genes cause racial behavioural differences and also that science cannot substantiate that belief”. Race, I argue, is a useful logical fiction.
- 3 October 2025
- Published by Center for Open Science in SocArXiv
Open AccessTowards a historical ontology of racial knowledge - the epistemic space of race
This paper outlines an epistemic space in which race is neither a biological fact nor a social construct. At stake is a tractable analysis of race across public discourse, science, and law which doesn’t reduce to the essentialism of biology or society.Drawing on Michel Foucault’s archaeology, biopolitics, and dispositif, and reading them alongside Kant’s Anthropology, I argue that race persists not because it is true or false, but because it is realised “within the true” - that is, within epistemic norms and institutional apparatuses that produce what Steven Pinker calls common knowledge, Michael Hardimon calls enlightened commonsense. Racial thinking is exemplified in Aaron Panofsky’s observation that “one can believe that genes cause racial behavioural differences and also that science cannot substantiate that belief”. Race, I argue, is a useful logical fiction.
- Open Access
- 23 May 2025
- Published by Center for Open Science in SocArXiv
Crisis, replicability, and reliability in modern science
This is a short essay on the meaning of the replication crisis. It was accepted as a paper for APPSA 2025 and LMPST Taiwan 2025. Unfortunately I was not able to attend; so I have expanded the paper and published it here. It addresses the following: What is replication? The views of classic philosophers of science about replication The idea of a crisis in scienceIs there a replication crisis? Reliability - widening the discussion about replication.The focus is on philosophy of science. That is, it is about the special status of scientific knowledge. TLDR, I argue that from a philosophical perspective the replication crisis is the reassertion of a broadly Popperian caricature of scientific method as value free enquiry; and that more recent philosophy of science, seen in the work of Nancy Cartwright, offers a more promising account of the role of replication in science.
- 23 May 2025
- Published by Center for Open Science in SocArXiv
Open AccessCrisis, replicability, and reliability in modern science
This is a short essay on the meaning of the replication crisis. It was accepted as a paper for APPSA 2025 and LMPST Taiwan 2025. Unfortunately I was not able to attend; so I have expanded the paper and published it here. It addresses the following: What is replication? The views of classic philosophers of science about replication The idea of a crisis in scienceIs there a replication crisis? Reliability - widening the discussion about replication.The focus is on philosophy of science. That is, it is about the special status of scientific knowledge. TLDR, I argue that from a philosophical perspective the replication crisis is the reassertion of a broadly Popperian caricature of scientific method as value free enquiry; and that more recent philosophy of science, seen in the work of Nancy Cartwright, offers a more promising account of the role of replication in science.
- Open Access
- 21 January 2025
- Published by Center for Open Science in SocArXiv
Blumenbach reconsidered - the epistemic space of race science in the nineteenth century
Viewing Johannes Blumenbach as the founder of modern race science reflects a style of intellectual history that emphasises the role of individuals in the transmission and communication of ideas. The limitations of this approach were highlighted in the 1960s by Quentin Skinner and Michel Foucault. The archaeological method developed by Foucault in the 1960s, along with his lectures and writings of the 1970s, provides resources to reconsider Blumenbach within an epistemic space of race science.
- 21 January 2025
- Published by Center for Open Science in SocArXiv
Open AccessBlumenbach reconsidered - the epistemic space of race science in the nineteenth century
Viewing Johannes Blumenbach as the founder of modern race science reflects a style of intellectual history that emphasises the role of individuals in the transmission and communication of ideas. The limitations of this approach were highlighted in the 1960s by Quentin Skinner and Michel Foucault. The archaeological method developed by Foucault in the 1960s, along with his lectures and writings of the 1970s, provides resources to reconsider Blumenbach within an epistemic space of race science.
- Open Access
- 30 April 2024
- Published by Center for Open Science in SocArXiv
Narratology - a part of humanistic history and philosophy of science
George Sarton's vision of humanistic science is challenged by events in the twentieth century. This paper proposes narratology as one of the ways in which a humanistic history of science can be revived in the twenty first century. It compares the narratologies of Gerard Genette and Roland Barthes, arguing that the latter offers a more compelling framework for science studies. This is a paper accepted for Convegno Nazionale SISS (Bari, 29-31 maggio 2024) . I am unfortunately unable to attend the conference and am making it available here.
- 30 April 2024
- Published by Center for Open Science in SocArXiv
Open AccessNarratology - a part of humanistic history and philosophy of science
George Sarton's vision of humanistic science is challenged by events in the twentieth century. This paper proposes narratology as one of the ways in which a humanistic history of science can be revived in the twenty first century. It compares the narratologies of Gerard Genette and Roland Barthes, arguing that the latter offers a more compelling framework for science studies. This is a paper accepted for Convegno Nazionale SISS (Bari, 29-31 maggio 2024) . I am unfortunately unable to attend the conference and am making it available here.
- Open Access
- 26 January 2024
- Published by Center for Open Science in SocArXiv
The narrative structure of scientific writing
The focus of this paper is the role of narrative in science. I argue that while recent narrative studies have tended to use the work of Gerard Genette, the approach of his contemporary Roland Barthes offers a more compelling and thoroughgoing basis for narrative science studies. The first section of the paper describes the relationship between science and language from the nineteenth century to the present. I argue that this relationship can be conceived in three linguistic turns: firstly, a general turning away of scientific from literary culture; secondly, the specialisation of scientific language in the nineteenth century culminating in logical empiricism; thirdly, the development of literature/science studies following the eclipse of logical empiricism. The second section provides an overview of recent scholarship on scientific writing, including the suggestion that narrative is a general purpose technology for science studies (Morgan 2022). This third section applies the generative model of narrative proposed in (Barthes 1970a) to a recent peer reviewed scientific paper, and finds that scientific and literary writing have the same narrative structure. The fourth section discusses some implications of this equivalence for modern science, including reproducibility, realism, and the role of scientific models.
- 26 January 2024
- Published by Center for Open Science in SocArXiv
Open AccessThe narrative structure of scientific writing
The focus of this paper is the role of narrative in science. I argue that while recent narrative studies have tended to use the work of Gerard Genette, the approach of his contemporary Roland Barthes offers a more compelling and thoroughgoing basis for narrative science studies. The first section of the paper describes the relationship between science and language from the nineteenth century to the present. I argue that this relationship can be conceived in three linguistic turns: firstly, a general turning away of scientific from literary culture; secondly, the specialisation of scientific language in the nineteenth century culminating in logical empiricism; thirdly, the development of literature/science studies following the eclipse of logical empiricism. The second section provides an overview of recent scholarship on scientific writing, including the suggestion that narrative is a general purpose technology for science studies (Morgan 2022). This third section applies the generative model of narrative proposed in (Barthes 1970a) to a recent peer reviewed scientific paper, and finds that scientific and literary writing have the same narrative structure. The fourth section discusses some implications of this equivalence for modern science, including reproducibility, realism, and the role of scientific models.
- Open Access
- 6 May 2021
- Published by Center for Open Science in SocArXiv
Wittgenstein and Foucault - a research note
This research note considers the extent to which Michel Foucault was familiar with the work of Ludwig Wittgenstein. It also describes Foucault’s account, in The order of things (OT), of the intellectual conditions that made Wittgenstein’s Tractatus Logico Philosophicus (TLP), and analytic philosophy more generally, possible. I argue that Foucault had little knowledge of either Wittgenstein or analytic philosophy until 1967, making the description about what made them possible in OT all the more compelling.
- 6 May 2021
- Published by Center for Open Science in SocArXiv
Open AccessWittgenstein and Foucault - a research note
This research note considers the extent to which Michel Foucault was familiar with the work of Ludwig Wittgenstein. It also describes Foucault’s account, in The order of things (OT), of the intellectual conditions that made Wittgenstein’s Tractatus Logico Philosophicus (TLP), and analytic philosophy more generally, possible. I argue that Foucault had little knowledge of either Wittgenstein or analytic philosophy until 1967, making the description about what made them possible in OT all the more compelling.
- Open Access
- 7 January 2021
- Published by Center for Open Science in SocArXiv
Locating narrative in scientific papers
This is a case study of the application of the narratological analysis in Roland Barthes' S/Z to a scientific paper.
- 7 January 2021
- Published by Center for Open Science in SocArXiv
Open AccessLocating narrative in scientific papers
This is a case study of the application of the narratological analysis in Roland Barthes' S/Z to a scientific paper.
- Open Access
- 8 December 2019
- Published by Center for Open Science in SocArXiv
Quantified bodies, exclusion, and the history of randomised clinical trials
Based on a paper given at the Conference on Quantification of Bodies, University of Coimbra November 2019. The standard historiography of clinical trials, at least in Britain, is built around the trial of streptomycin as a treatment for tuberculosis organised by the UK Medical Research Council (MRC) in the late 1940s. A series of clinical trials took place in Glasgow in the 1930s which doesn’t feature in the standard account. The reasons for their exclusion, and why they did take place, are the subject of this paper.In recovering the context in which the Glasgow clinical trials took place three factors stand out. Firstly, the practice operated by the Glasgow Corporation of treating most cases of skin infection by hospitalising patients. Secondly, the high degree of interconnectivity between voluntary and state-funded hospitals in Glasgow at the time. Thirdly, the belief of Thomas Anderson in the value of biometry as a basis for evaluating therapies.These factors can be given names. The first is the moral economy of medicine - the practice of establishing fever and isolation hospitals as part of hospital provision in Glasgow in the nineteenth century. The second is the political economy of medicine - the relationships among doctors, especially the degree of interconnectedness between the health systems associated with the University of Glasgow and the Corporation of Glasgow. The third is the mathematization of causality - in this case, the biometric sensibilities of Thomas Anderson: his understanding of, expertise, and belief in, the efficacy of quantification as a means of progress in scientific medicine.
- 8 December 2019
- Published by Center for Open Science in SocArXiv
Open AccessQuantified bodies, exclusion, and the history of randomised clinical trials
Based on a paper given at the Conference on Quantification of Bodies, University of Coimbra November 2019. The standard historiography of clinical trials, at least in Britain, is built around the trial of streptomycin as a treatment for tuberculosis organised by the UK Medical Research Council (MRC) in the late 1940s. A series of clinical trials took place in Glasgow in the 1930s which doesn’t feature in the standard account. The reasons for their exclusion, and why they did take place, are the subject of this paper.In recovering the context in which the Glasgow clinical trials took place three factors stand out. Firstly, the practice operated by the Glasgow Corporation of treating most cases of skin infection by hospitalising patients. Secondly, the high degree of interconnectivity between voluntary and state-funded hospitals in Glasgow at the time. Thirdly, the belief of Thomas Anderson in the value of biometry as a basis for evaluating therapies.These factors can be given names. The first is the moral economy of medicine - the practice of establishing fever and isolation hospitals as part of hospital provision in Glasgow in the nineteenth century. The second is the political economy of medicine - the relationships among doctors, especially the degree of interconnectedness between the health systems associated with the University of Glasgow and the Corporation of Glasgow. The third is the mathematization of causality - in this case, the biometric sensibilities of Thomas Anderson: his understanding of, expertise, and belief in, the efficacy of quantification as a means of progress in scientific medicine.
- 4 July 2019
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 112 (7) , 304-312
Pioneering controlled trials of treatments for erysipelas and pneumonia in Glasgow, 1936–1947
- 4 July 2019
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 112 (7) , 304-312
Pioneering controlled trials of treatments for erysipelas and pneumonia in Glasgow, 1936–1947
- Open Access
- 29 August 2017
- Published by Center for Open Science in Thesis Commons
Clinical trials in British Medicine 1858-1948, with special reference to the development of the randomised controlled trial
This thesis arose from a desire to explore the reasons for two related phenomena: whyrandomisation wasn’t introduced into clinical trials before the 1940s, and why in 1947 itwas. In seeking to answer these questions, this study focuses on the development ofclinical trials in Britain from the mid-nineteenth century to the MRC streptomycin trialpublished in 1948.Control groups and quasi-random allocation and were known to British clinicians in thenineteenth century, well before they became formalised in statistical theory. Chapter twoargues that the collective therapeutic enquiries of the 1860s were an attempt to reform themedical profession in the light of the deficiencies of the 1858 Medical Act. Reform inthis context was an attempt to create an ‘ideal practitioner’, defined here as one who useda statistical style of knowledge to guide both medical practice and medical etiquette.However, methodological elements such as control groups were largely irrelevant to thisenterprise.Collective enquiries were overshadowed by the possibility of an exact knowledge oftherapeutic action. Drugs such as diphtheria anti-toxin and Salvarsan, both products ofGerman laboratories, mark the beginning of the modern era of therapeutics. Clinical trialsplayed a secondary role in the development and testing of such drugs. Biologicalstandardisation offered a powerful way for drug companies, research laboratories, andstate authorities to promote and regulate the new laboratory based drugs.At the British Medical Research Council, physiological research in a laboratory wasregarded as the desirable way to test new drugs. As a result, clinical trials organised bythe MRC in the 1930s are historically inconsequential. Nevertheless, they played a role inconsolidating the position of the MRC as the leading medical research organisation inBritain at a time when pharmaceutical companies were beginning to produce a range ofnew therapies.The organisational challenges facing the MRC in the immediate post-war period werechanged considerably by the coming of the NHS. Adoption of a more strictly designedform of randomised controlled trial offered the MRC some specific advantages whendealing with a drug such as streptomycin. Using unpublished archival sources, theorganisation of the streptomycin trial is reconstructed, and the organisational advantagesof an RCT design highlighted.
- 29 August 2017
- Published by Center for Open Science in Thesis Commons
Open AccessClinical trials in British Medicine 1858-1948, with special reference to the development of the randomised controlled trial
This thesis arose from a desire to explore the reasons for two related phenomena: whyrandomisation wasn’t introduced into clinical trials before the 1940s, and why in 1947 itwas. In seeking to answer these questions, this study focuses on the development ofclinical trials in Britain from the mid-nineteenth century to the MRC streptomycin trialpublished in 1948.Control groups and quasi-random allocation and were known to British clinicians in thenineteenth century, well before they became formalised in statistical theory. Chapter twoargues that the collective therapeutic enquiries of the 1860s were an attempt to reform themedical profession in the light of the deficiencies of the 1858 Medical Act. Reform inthis context was an attempt to create an ‘ideal practitioner’, defined here as one who useda statistical style of knowledge to guide both medical practice and medical etiquette.However, methodological elements such as control groups were largely irrelevant to thisenterprise.Collective enquiries were overshadowed by the possibility of an exact knowledge oftherapeutic action. Drugs such as diphtheria anti-toxin and Salvarsan, both products ofGerman laboratories, mark the beginning of the modern era of therapeutics. Clinical trialsplayed a secondary role in the development and testing of such drugs. Biologicalstandardisation offered a powerful way for drug companies, research laboratories, andstate authorities to promote and regulate the new laboratory based drugs.At the British Medical Research Council, physiological research in a laboratory wasregarded as the desirable way to test new drugs. As a result, clinical trials organised bythe MRC in the 1930s are historically inconsequential. Nevertheless, they played a role inconsolidating the position of the MRC as the leading medical research organisation inBritain at a time when pharmaceutical companies were beginning to produce a range ofnew therapies.The organisational challenges facing the MRC in the immediate post-war period werechanged considerably by the coming of the NHS. Adoption of a more strictly designedform of randomised controlled trial offered the MRC some specific advantages whendealing with a drug such as streptomycin. Using unpublished archival sources, theorganisation of the streptomycin trial is reconstructed, and the organisational advantagesof an RCT design highlighted.